GlassScriptPhysician profile
Craig S Bindi
NPI 1689794992
$941.99
in general payments reported to CMS, 2019-2025
9 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $161 · 2021: $140 · 2023: $156 · 2024: $23.86 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337 · Gift: $72.12 · Education: $10.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.28 |
| Gift | $72.12 |
| Education | $10.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $219.03 | 2021-2025 | Visumax |
| Rxsight INC | $158.20 | 2023-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece |
| Novartis Pharmaceuticals Corporation | $144.01 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.39 | 2019-2021 | |
| Alcon Vision LLC | $101.45 | 2019-2025 | Wavelight Sightmap |
| Kala Pharmaceuticals, INC. | $84.14 | 2019-2020 | |
| Shire North American Group INC | $40.04 | 2019 | |
| Carl Zeiss Meditec, INC. | $36.79 | 2019-2020 | |
| Carl Zeiss Meditec Cataract Technology INC. | $21.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Bindi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.